VerifiedBiotechnology Research

Renalytix

Renalytix (LSE: RENX)(NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.™

7-day free trial · no credit card

United States55(51 to 200)$1M to <$10Mrenalytix.com LinkedIn

Verified contacts

available on Kipplo

LinkedIn employees

51 to 200 range

Open roles

—

no listings

Distinct roles

indexed titles

Tech stack

tools in use

Monthly traffic

399

organic / mo

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

47 contacts with verified email or phone · masked until revealed.

Showing 9 of 47 verified contacts

Top roles at Renalytix

37 distinct titles indexed · top 10 shown.

2-,
2co-founder
2director, quality system compliance and eh & s
2kidney account executive
2kidney health account executive
1()
1billing reimbursement specialist
1billing specialist
1board secretary
1brand, content & marketing leader (life sciences, biotech, diagnostics)
+27more titles

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 47 verified contacts at Renalytix

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.